Company Update: SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in CBM | Learn More
Logo yposkesi
waves image

Meet our team at Cell and Gene on the Med: April 9-11, 2024 in Rome, Italy.

The event

The Cell and Gene on the Med conference will take place April 9-11 2024 at the Rome Cavalieri Waldorf Astoria Hotel in Rome, Italy.

Learn more about the event

Our team

Our team

Meet our team during the event: 


Meet our team during the Cell and Gene on the Med conference and learn more about our extended services to bring your cell and gene therapies to life… SK pharmteco is assembling the most accomplished cell and gene therapy experts in the world, armed with cutting-edge and innovative technologies, to offer scalable, end-to-end, best-in-class services from pre-clinical through commercial, including:

  • Process development
  • Plasmid DNA
  • Vector manufacturing
  • Cell banking
  • Cell processing
  • A full suite of complementary and standalone testing and analytical capabilities.

Learn more about our newly launched Viral Vector Manufacturing Platform: LentiSure™ and AAVelocity!

At the beginning of April 2023, Yposkesi launched its new Lentiviral Vector Manufacturing Platform, LentiSure.

LentiSure is providing the premium quality grade lentiviral vectors you need to assure your clinical development and commercial cell and gene therapy pipeline. LentiSure’s robust, scalable, and plug & play-optimized processes enable you to accelerate the time to market of your cell and gene therapies and facilitate better patient outcomes. You obtain a safe and effective product through LentiSure’s high productivity and established analytical methods. LentiSure is the choice for high titers, transduction efficiency, reliability, and accessing scalable production processes with optimized purification techniques.

Schedule a meeting
Created by Yerokhoff Kostyiantine